Inventor
TRAUTWEIN NICO
DE10 patents
Patents
10 patentsUS11542303B2Jan 3, 2023
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations71
US11135246B2Oct 5, 2021
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations71
US11559550B2Jan 24, 2023
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11560405B2Jan 24, 2023
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11427614B2Aug 30, 2022
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11103534B2Aug 31, 2021
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11020432B2Jun 1, 2021
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11007223B2May 18, 2021
Peptides and combination thereof for use in the immunotherapy against cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US10993963B2May 4, 2021
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US10899819B2Jan 26, 2021
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations59